Evangelos Giamarellos-Bourboulis
Evangelos Giamarellos-Bourboulis
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
SC Cheng, J Quintin, RA Cramer, KM Shepardson, S Saeed, V Kumar, ...
Science 345 (6204), 2014
7872014
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ...
science 345 (6204), 2014
7252014
Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes
J Quintin, S Saeed, JHA Martens, EJ Giamarellos-Bourboulis, DC Ifrim, ...
Cell host & microbe 12 (2), 223-232, 2012
5152012
Carrier systems for the local delivery of antibiotics in bone infections
K Kanellakopoulou, EJ Giamarellos-Bourboulis
Drugs 59 (6), 1223-1232, 2000
3482000
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
B Ferwerda, MBB McCall, S Alonso, EJ Giamarellos-Bourboulis, ...
Proceedings of the National Academy of Sciences 104 (42), 16645-16650, 2007
3272007
What causes hidradenitis suppurativa?
L Ralf Paus, H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ...
Experimental dermatology 17 (5), 455-456, 2008
3052008
Azithromycin: mechanisms of action and their relevance for clinical applications
MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ...
Pharmacology & therapeutics 143 (2), 225-245, 2014
2652014
Two phase 3 trials of adalimumab for hidradenitis suppurativa
AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ...
New England Journal of Medicine 375 (5), 422-434, 2016
2562016
Benefits of a synbiotic formula (Synbiotic 2000ForteŽ) in critically ill trauma patients: early results of a randomized controlled trial
K Kotzampassi, EJ Giamarellos-Bourboulis, A Voudouris, P Kazamias, ...
World journal of surgery 30 (10), 1848-1855, 2006
2232006
Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators
EJ Giamarellos-Bourboulis
International journal of antimicrobial agents 31 (1), 12-20, 2008
2222008
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
EJ Giamarellos-Bourboulis, A Mega, P Grecka, N Scarpa, G Koratzanis, ...
Intensive care medicine 28 (9), 1351-1356, 2002
2202002
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
SC Cheng, BP Scicluna, RJW Arts, MS Gresnigt, E Lachmandas, ...
Nature immunology 17 (4), 406-413, 2016
2152016
Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis
LAB Joosten, MG Netea, E Mylona, MI Koenders, RKS Malireddi, ...
Arthritis & Rheumatism 62 (11), 3237-3248, 2010
2152010
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
EJ Giamarellos-Bourboulis, JC Pechere, C Routsi, D Plachouras, ...
Clinical Infectious Diseases 46 (8), 1157-1164, 2008
2072008
Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii
EJ Giamarellos-Bourboulis, E Xirouchaki, H Giamarellou
Diagnostic microbiology and infectious disease 40 (3), 117-120, 2001
1602001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia
DM Livermore, MW Carter, S Bagel, B Wiedemann, F Baquero, E Loza, ...
Antimicrobial Agents and Chemotherapy 45 (6), 1860-1867, 2001
1602001
Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia
EJ Giamarellos-Bourboulis, P Grecka, G Poulakou, K Anargyrou, ...
Clinical infectious diseases 32 (12), 1718-1725, 2001
1582001
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome
E Pyleris, EJ Giamarellos-Bourboulis, D Tzivras, V Koussoulas, ...
Digestive diseases and sciences 57 (5), 1321-1329, 2012
1502012
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ...
Nature immunology 18 (8), 826, 2017
1472017
An open‐label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
EJ Giamarellos‐Bourboulis, E Pelekanou, A Antonopoulou, ...
British Journal of Dermatology 158 (3), 567-572, 2008
1382008
The system can't perform the operation now. Try again later.
Articles 1–20